Pharma & Healthcare
Global Psoriasis Treatment Drugs Market Research Report 2025
- Mar 11, 25
- ID: 29322
- Pages: 83
- Figures: 81
- Views: 60
The global market for Psoriasis Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriasis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Treatment Drugs.
The Psoriasis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Segment by Type
TNF Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Corticosteroids
Others
Segment by Application
Oral
Parenteral
Topical
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriasis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Treatment Drugs.
The Psoriasis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Segment by Type
TNF Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Corticosteroids
Others
Segment by Application
Oral
Parenteral
Topical
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 TNF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 Vitamin D Analogs
1.2.5 Corticosteroids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Psoriasis Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Treatment Drugs Market Perspective (2020-2031)
2.2 Global Psoriasis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriasis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Psoriasis Treatment Drugs Market Dynamics
2.3.1 Psoriasis Treatment Drugs Industry Trends
2.3.2 Psoriasis Treatment Drugs Market Drivers
2.3.3 Psoriasis Treatment Drugs Market Challenges
2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriasis Treatment Drugs Revenue
3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2024
3.5 Global Key Players of Psoriasis Treatment Drugs Head office and Area Served
3.6 Global Key Players of Psoriasis Treatment Drugs, Product and Application
3.7 Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Psoriasis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriasis Treatment Drugs Market Size (2020-2031)
6.2 North America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriasis Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Psoriasis Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriasis Treatment Drugs Market Size (2020-2031)
7.2 Europe Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Psoriasis Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriasis Treatment Drugs Market Size (2020-2031)
9.2 Latin America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Psoriasis Treatment Drugs Introduction
11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Psoriasis Treatment Drugs Introduction
11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Dermira
11.3.1 Dermira Company Details
11.3.2 Dermira Business Overview
11.3.3 Dermira Psoriasis Treatment Drugs Introduction
11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.3.5 Dermira Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Psoriasis Treatment Drugs Introduction
11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Psoriasis Treatment Drugs Introduction
11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.7.5 Johnson & Johnson Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.10.5 AbbVie Recent Development
11.11 LEO Pharma
11.11.1 LEO Pharma Company Details
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.11.5 LEO Pharma Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Psoriasis Treatment Drugs Introduction
11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.12.5 Biogen Recent Development
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Details
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.13.5 Galectin Therapeutics Recent Development
11.14 Cellceutix
11.14.1 Cellceutix Company Details
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.14.5 Cellceutix Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Psoriasis Treatment Drugs Introduction
11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 TNF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 Vitamin D Analogs
1.2.5 Corticosteroids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Psoriasis Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Treatment Drugs Market Perspective (2020-2031)
2.2 Global Psoriasis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriasis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Psoriasis Treatment Drugs Market Dynamics
2.3.1 Psoriasis Treatment Drugs Industry Trends
2.3.2 Psoriasis Treatment Drugs Market Drivers
2.3.3 Psoriasis Treatment Drugs Market Challenges
2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriasis Treatment Drugs Revenue
3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2024
3.5 Global Key Players of Psoriasis Treatment Drugs Head office and Area Served
3.6 Global Key Players of Psoriasis Treatment Drugs, Product and Application
3.7 Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Psoriasis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriasis Treatment Drugs Market Size (2020-2031)
6.2 North America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriasis Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Psoriasis Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriasis Treatment Drugs Market Size (2020-2031)
7.2 Europe Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Psoriasis Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriasis Treatment Drugs Market Size (2020-2031)
9.2 Latin America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Psoriasis Treatment Drugs Introduction
11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Psoriasis Treatment Drugs Introduction
11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Dermira
11.3.1 Dermira Company Details
11.3.2 Dermira Business Overview
11.3.3 Dermira Psoriasis Treatment Drugs Introduction
11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.3.5 Dermira Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Psoriasis Treatment Drugs Introduction
11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Psoriasis Treatment Drugs Introduction
11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.7.5 Johnson & Johnson Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.10.5 AbbVie Recent Development
11.11 LEO Pharma
11.11.1 LEO Pharma Company Details
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.11.5 LEO Pharma Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Psoriasis Treatment Drugs Introduction
11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.12.5 Biogen Recent Development
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Details
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.13.5 Galectin Therapeutics Recent Development
11.14 Cellceutix
11.14.1 Cellceutix Company Details
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.14.5 Cellceutix Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Psoriasis Treatment Drugs Introduction
11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Psoriasis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of Interleukin Inhibitors
Table 4. Key Players of Vitamin D Analogs
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Others
Table 7. Global Psoriasis Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriasis Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Psoriasis Treatment Drugs Market Share by Region (2020-2025)
Table 11. Global Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Psoriasis Treatment Drugs Market Share by Region (2026-2031)
Table 13. Psoriasis Treatment Drugs Market Trends
Table 14. Psoriasis Treatment Drugs Market Drivers
Table 15. Psoriasis Treatment Drugs Market Challenges
Table 16. Psoriasis Treatment Drugs Market Restraints
Table 17. Global Psoriasis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Psoriasis Treatment Drugs Market Share by Players (2020-2025)
Table 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)
Table 20. Ranking of Global Top Psoriasis Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Psoriasis Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Psoriasis Treatment Drugs, Headquarters and Area Served
Table 23. Global Key Players of Psoriasis Treatment Drugs, Product and Application
Table 24. Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Psoriasis Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Psoriasis Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Psoriasis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Amgen Company Details
Table 50. Amgen Business Overview
Table 51. Amgen Psoriasis Treatment Drugs Product
Table 52. Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Allergan Company Details
Table 55. Allergan Business Overview
Table 56. Allergan Psoriasis Treatment Drugs Product
Table 57. Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Dermira Company Details
Table 60. Dermira Business Overview
Table 61. Dermira Psoriasis Treatment Drugs Product
Table 62. Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 63. Dermira Recent Development
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Psoriasis Treatment Drugs Product
Table 67. Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Psoriasis Treatment Drugs Product
Table 72. Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Psoriasis Treatment Drugs Product
Table 77. Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Psoriasis Treatment Drugs Product
Table 82. Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Psoriasis Treatment Drugs Product
Table 87. Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Psoriasis Treatment Drugs Product
Table 92. AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Psoriasis Treatment Drugs Product
Table 97. AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. LEO Pharma Company Details
Table 100. LEO Pharma Business Overview
Table 101. LEO Pharma Psoriasis Treatment Drugs Product
Table 102. LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 103. LEO Pharma Recent Development
Table 104. Biogen Company Details
Table 105. Biogen Business Overview
Table 106. Biogen Psoriasis Treatment Drugs Product
Table 107. Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 108. Biogen Recent Development
Table 109. Galectin Therapeutics Company Details
Table 110. Galectin Therapeutics Business Overview
Table 111. Galectin Therapeutics Psoriasis Treatment Drugs Product
Table 112. Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 113. Galectin Therapeutics Recent Development
Table 114. Cellceutix Company Details
Table 115. Cellceutix Business Overview
Table 116. Cellceutix Psoriasis Treatment Drugs Product
Table 117. Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 118. Cellceutix Recent Development
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Psoriasis Treatment Drugs Product
Table 122. Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 123. Bayer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Psoriasis Treatment Drugs Picture
Figure 2. Global Psoriasis Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriasis Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. TNF Inhibitors Features
Figure 5. Interleukin Inhibitors Features
Figure 6. Vitamin D Analogs Features
Figure 7. Corticosteroids Features
Figure 8. Others Features
Figure 9. Global Psoriasis Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Psoriasis Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 11. Oral Case Studies
Figure 12. Parenteral Case Studies
Figure 13. Topical Case Studies
Figure 14. Psoriasis Treatment Drugs Report Years Considered
Figure 15. Global Psoriasis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Psoriasis Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Psoriasis Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Psoriasis Treatment Drugs Market Share by Players in 2024
Figure 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2024
Figure 21. North America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 23. United States Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 27. Germany Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Psoriasis Treatment Drugs Market Share by Region (2020-2031)
Figure 35. China Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 51. Allergan Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 52. Dermira Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 54. Novartis Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 59. AbbVie Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 60. LEO Pharma Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 61. Biogen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 62. Galectin Therapeutics Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 63. Cellceutix Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 64. Bayer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Psoriasis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of Interleukin Inhibitors
Table 4. Key Players of Vitamin D Analogs
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Others
Table 7. Global Psoriasis Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriasis Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Psoriasis Treatment Drugs Market Share by Region (2020-2025)
Table 11. Global Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Psoriasis Treatment Drugs Market Share by Region (2026-2031)
Table 13. Psoriasis Treatment Drugs Market Trends
Table 14. Psoriasis Treatment Drugs Market Drivers
Table 15. Psoriasis Treatment Drugs Market Challenges
Table 16. Psoriasis Treatment Drugs Market Restraints
Table 17. Global Psoriasis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Psoriasis Treatment Drugs Market Share by Players (2020-2025)
Table 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)
Table 20. Ranking of Global Top Psoriasis Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Psoriasis Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Psoriasis Treatment Drugs, Headquarters and Area Served
Table 23. Global Key Players of Psoriasis Treatment Drugs, Product and Application
Table 24. Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Psoriasis Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Psoriasis Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Psoriasis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Amgen Company Details
Table 50. Amgen Business Overview
Table 51. Amgen Psoriasis Treatment Drugs Product
Table 52. Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Allergan Company Details
Table 55. Allergan Business Overview
Table 56. Allergan Psoriasis Treatment Drugs Product
Table 57. Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Dermira Company Details
Table 60. Dermira Business Overview
Table 61. Dermira Psoriasis Treatment Drugs Product
Table 62. Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 63. Dermira Recent Development
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Psoriasis Treatment Drugs Product
Table 67. Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Psoriasis Treatment Drugs Product
Table 72. Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Psoriasis Treatment Drugs Product
Table 77. Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Psoriasis Treatment Drugs Product
Table 82. Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Psoriasis Treatment Drugs Product
Table 87. Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Psoriasis Treatment Drugs Product
Table 92. AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Psoriasis Treatment Drugs Product
Table 97. AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. LEO Pharma Company Details
Table 100. LEO Pharma Business Overview
Table 101. LEO Pharma Psoriasis Treatment Drugs Product
Table 102. LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 103. LEO Pharma Recent Development
Table 104. Biogen Company Details
Table 105. Biogen Business Overview
Table 106. Biogen Psoriasis Treatment Drugs Product
Table 107. Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 108. Biogen Recent Development
Table 109. Galectin Therapeutics Company Details
Table 110. Galectin Therapeutics Business Overview
Table 111. Galectin Therapeutics Psoriasis Treatment Drugs Product
Table 112. Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 113. Galectin Therapeutics Recent Development
Table 114. Cellceutix Company Details
Table 115. Cellceutix Business Overview
Table 116. Cellceutix Psoriasis Treatment Drugs Product
Table 117. Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 118. Cellceutix Recent Development
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Psoriasis Treatment Drugs Product
Table 122. Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 123. Bayer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Psoriasis Treatment Drugs Picture
Figure 2. Global Psoriasis Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriasis Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. TNF Inhibitors Features
Figure 5. Interleukin Inhibitors Features
Figure 6. Vitamin D Analogs Features
Figure 7. Corticosteroids Features
Figure 8. Others Features
Figure 9. Global Psoriasis Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Psoriasis Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 11. Oral Case Studies
Figure 12. Parenteral Case Studies
Figure 13. Topical Case Studies
Figure 14. Psoriasis Treatment Drugs Report Years Considered
Figure 15. Global Psoriasis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Psoriasis Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Psoriasis Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Psoriasis Treatment Drugs Market Share by Players in 2024
Figure 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2024
Figure 21. North America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 23. United States Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 27. Germany Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Psoriasis Treatment Drugs Market Share by Region (2020-2031)
Figure 35. China Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Psoriasis Treatment Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 51. Allergan Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 52. Dermira Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 54. Novartis Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 56. Johnson & Johnson Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 59. AbbVie Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 60. LEO Pharma Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 61. Biogen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 62. Galectin Therapeutics Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 63. Cellceutix Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 64. Bayer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232